Edwards Lifesciences Corp.
(NYSE : EW)

( )
EW After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.17%595.001.0%$716.43m
DHRDanaher Corp. -1.01%294.260.7%$614.73m
ISRGIntuitive Surgical, Inc. -0.05%229.590.8%$496.76m
MDTMedtronic Plc 0.37%95.260.6%$430.11m
ABTAbbott Laboratories -0.53%109.970.8%$423.84m
SYKStryker Corp. -0.14%221.131.3%$349.84m
BSXBoston Scientific Corp. 0.52%42.651.0%$298.33m
DXCMDexCom, Inc. -0.69%87.531.9%$264.54m
ALGNAlign Technology, Inc. 1.44%281.666.4%$259.22m
EWEdwards Lifesciences Corp. -1.02%99.510.4%$251.14m
BDXBecton, Dickinson & Co. -0.13%263.881.0%$230.54m
IDXXIDEXX Laboratories, Inc. 0.20%374.753.9%$220.19m
AAgilent Technologies, Inc. -1.50%140.161.7%$204.22m
BAXBaxter International, Inc. -0.52%61.061.8%$201.48m
MASIMasimo Corp. -3.39%159.935.1%$192.34m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring systems measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.